Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial.

Frederik PerssonStephen C BainOfri MosenzonHiddo J L HeerspinkJohannes F E Mann Hiddo J Lambers HeerspinkItamar RazItamar RazSøren RasmussenBernt Johan von ScholtenEllen Burgessnull null

Published in: Diabetes care (2021)

A reduction in albuminuria during the 1st year was associated with fewer cardiovascular and renal outcomes, independent of treatment. Albuminuria monitoring remains an important part of diabetes care, with great unused potential.

Keyphrases

type diabetes
glycemic control
study protocol
clinical trial
phase iii
randomized controlled trial
insulin resistance
combination therapy
smoking cessation